Research has demonstrated that NLRP3 is implicated in the pathophysiology of SLE, mediates the pathogenicity of autoantibodies and type-I interferon (IFN-I), and interacts with NF-κB and other pathways to control T and B cell differentiation [171]. This evidence concerns the gene NLRP3 and systemic lupus erythematosus.